Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 10-Q Report Quarterly Report
  3. SC 13D Stake Beneficial Ownership Report
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13D Stake Beneficial Ownership Report
  6. 4 Open-market buy 10% owner bought 200,000 shares at $15.00 ($3,000,000)
  7. 4 Conversion 10% owner acquired 1,906,191 shares (conversion)
  8. SC 13G Stake Amended Statement of Ownership
  9. 4 Open-market buy Director bought 200,000 shares at $15.00 ($3,000,000)
  10. 4 Open-market buy 10% owner bought 550,000 shares at $15.00 ($8,250,000)
  11. 4 Open-market buy 10% owner bought 200,000 shares at $15.00 ($3,000,000)
  12. 4 Conversion See Remarks acquired 18,517 shares (conversion)
  13. 4 Conversion See Remarks acquired 9,258 shares (conversion)
  14. 4 Conversion Director acquired 3,092,340 shares (conversion)
  15. 4 Conversion Chief Executive Officer acquired 273,058 shares (conversion)
  16. 4 Conversion President acquired 273,057 shares (conversion)
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 8-K Event Bylaws or fiscal year change · Other events
  19. 424B4 Offering Prospectus
  20. EFFECT Other Notice of Effectiveness

Page 16 of 18 · 348 filings